Active, not recruitingEarly Phase 1NCT03560960

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Boston University
Principal Investigator
Wendy Qiu, MD PhD
Boston Medical Center and BUSM
Intervention
Pramlintide challenge test(drug)
Enrollment
57 enrolled
Eligibility
60-90 years · All sexes
Timeline
2020 – 2026

Study locations (3)

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03560960 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials